Ischaemic heart disease: risk stratification and intervention. Risk of progression of coronary artery disease.
D000328:Adult; D000368:Aged; D001053:Apolipoproteins / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control / Q000523:psychology; D005260:Female; D006487:Hemostasis; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D015228:Hypertriglyceridemia / Q000150:complications / Q000517:prevention & control; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D005082:Physical Exertion; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D001053:Apolipoproteins; D001779:Blood Coagulation Factors; D017270:Lipoprotein(a); D008074:Lipoproteins